VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model

References

1. Arnoldo A., Curak J., Kittanakom S., Chevelev I., Lee V. T., Sahebol-Amri M., Koscik B., Ljuma L., Roy P. J. other authors 2008; Identification of small molecule inhibitors of Pseudomonas aeruginosa Exoenzyme S using a yeast phenotypic screen. PLoS Genet 4:e1000005 [CrossRef]
   [Google Scholar]
2. Chen Y., Johnson J. A., Pusch G. D., Morris J. G. Jr, Stine O. C. (2007; The genome of non-O1 Vibrio cholerae NRT 36S demonstrates the presence of pathogenic mechanisms that are distinct from O1 Vibrio cholerae . Infect Immun 75:2645–2647 [CrossRef]
   [Google Scholar]
3. Dean P., Maresca M., Kenny B. 2005; EPEC's weapons of mass subversion. Curr Opin Microbiol 8:28–34 [CrossRef]
   [Google Scholar]
4. Dziejman M., Serruto D., Tam V. C., Sturtevant D., Diraphat P., Faruque S. M., Rahman H. M., Heidelberg J. F., Decker J. other authors 2005; Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A 102:3465–3470 [CrossRef]
   [Google Scholar]
5. Hassane D. C., Lee R. B., Mendenhall M. D., Pickett C. L. 2001; Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun 69:5752–5759 [CrossRef]
   [Google Scholar]
6. Hayward R. D., Koronakis V. 2002; Direct modulation of the host cell cytoskeleton by Salmonella actin-binding proteins. Trends Cell Biol 12:15–20 [CrossRef]
   [Google Scholar]
7. Huang J., Lesser C. F., Lory S. 2008; The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth. Nature 456:112–115 [CrossRef]
   [Google Scholar]
8. Jewett T. J., Fischer E. R., Mead D. J., Hackstadt T. 2006; Chlamydia TARP is a bacterial nucleator of actin. Proc Natl Acad Sci U S A 103:15599–15604 [CrossRef]
   [Google Scholar]
9. Joelsson A., Liu Z., Zhu J. 2006; Genetic and phenotypic diversity of quorum sensing systems in clinical and environmental isolates of Vibrio cholerae . Infect Immun 74:1141–1147 [CrossRef]
   [Google Scholar]
10. Lesser C. F., Miller S. I. 2001; Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection. EMBO J 20:1840–1849 [CrossRef]
    [Google Scholar]
11. Liverman A. D. B., Cheng H.-C., Trosky J. E., Leung D. W., Yarbrough M. L., Burdette D. L., Rosen M. K., Orth K. 2007; Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A 104:17117–17122 [CrossRef]
    [Google Scholar]
12. McMillan J. N., Sia R. A. L., Lew D. J. 1998; A morphogenesis checkpoint monitors the actin cytoskeleton in yeast. J Cell Biol 142:1487–1499 [CrossRef]
    [Google Scholar]
13. Nejedlik L., Pierfelice T., Geiser J. R. 2004; Actin distribution is disrupted upon expression of Yersinia YopO/YpkA in yeast. Yeast 21:759–768 [CrossRef]
    [Google Scholar]
14. Quinlan M. E., Heuser J. A., Kerkhoff E., Mullins R. D. 2005; Drosophila Spire is an actin nucleation factor. Nature 433:382–388 [CrossRef]
    [Google Scholar]
15. Rabin S. D., Hauser A. R. 2003; Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae . Infect Immun 71:4144–4150 [CrossRef]
    [Google Scholar]
16. Raychaudhuri S., Jain V., Dongre M. 2006; The identification of a constitutively active variant of LuxO that affects the production of HA/protease and biofilm development in a non-O1, non-O139 strain Vibrio cholerae O110. Gene 369:126–133 [CrossRef]
    [Google Scholar]
17. Rodríguez-Escudero I., Hardwidge P. R., Nombela C., Cid V. J., Finlay B. B., Molina M. 2005; Enteropathogenic Escherichia coli type III effectors alter cytoskeletal function and signaling in Saccharomyces cerevisiae . Microbiology 151:2933–2945 [CrossRef]
    [Google Scholar]
18. Rodríguez-Pachón J. M., Martín H., North G., Rotger R., Nombela C., Molina M. 2002; A novel connection between the yeast Cdc42 GTPase and the Slt2-mediated cell integrity pathway identified through the effect of secreted Salmonella GTPase modulators. J Biol Chem 277:27094–27102 [CrossRef]
    [Google Scholar]
19. Sato H., Frank D. W., Hillard C. J., Feix J. B., Pankhaniya R. R., Moriyama K., Finck-Barbancon V., Buchaklian A., Lei M. other authors 2003; The mechanism of action of the Pseudomonas aeruginosa encoded type III cytotoxin, ExoU. EMBO J 22:2959–2969 [CrossRef]
    [Google Scholar]
20. Shohdy N., Efe J. A., Emr S. D., Shuman H. A. 2005; Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking. Proc Natl Acad Sci U S A 102:4866–4871 [CrossRef]
    [Google Scholar]
21. Sturgill T. W., Cohen A., Diefenbacher M., Trautwein M., Martin D. E., Hall M. N. 2008; Tor1 and Tor2 have distinct locations in live cells. Eukaryot Cell 7:1819–1830 [CrossRef]
    [Google Scholar]
22. Tam V. C., Serruto D., Dziejman M., Brieher W., Mekalanos J. J. 2007; A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 1:95–107 [CrossRef]
    [Google Scholar]
23. Tran Van Nhieu G., Caron E., Hall A., Sansonetti P. J. 1999; IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J 18:3249–3262 [CrossRef]
    [Google Scholar]
24. Trosky J. E., Mukherjee S., Burdette D. L., Roberts M., McCarter L., Siegel R. M., Orth K. 2004; Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus . J Biol Chem 279:51953–51957 [CrossRef]
    [Google Scholar]
25. Valdivia R. H. 2004; Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae . Eukaryot Cell 3:827–834 [CrossRef]
    [Google Scholar]
26. Von Pawel-Rammingen U., Telepnev M. V., Schmidt G., Aktories K., Wolf-Watz H., Rosqvist R. 2000; GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol 36:737–748
    [Google Scholar]
27. Yoon S., Liu Z., Eyobo Y., Orth K. 2003; Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism. J Biol Chem 278:2131–2135 [CrossRef]
    [Google Scholar]